# Hermann Einsele

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hermann-einsele/

## Facts

| Field | Value |
| --- | --- |
| Citations | 75,720 |
| Field | Multiple Myeloma Research and Treatments |
| h-index | 140 |
| i10-index | 735 |
| Last Known Institution | Universitätsklinikum Würzburg |
| OpenAlex ID | https://openalex.org/A5016360607 |
| ORCID iD | https://orcid.org/0000-0002-7680-0819 |
| Works | 1,624 |

## Researcher papers

- [Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma](https://scholariq.org/papers/idecabtagene-vicleucel-in-relapsed-and-refractory-multiple-myeloma/)
- [Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma](https://scholariq.org/papers/daratumumab-bortezomib-lenalidomide-and-dexamethasone-for-multiple-myeloma/)
- [LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma](https://scholariq.org/papers/locommotion-a-prospective-non-interventional-multinational-study-of-real-life/)
- [Proof of concept for a rapidly switchable universal CAR-T platform with UniCAR-T-CD123 in relapsed/refractory AML](https://scholariq.org/papers/proof-of-concept-for-a-rapidly-switchable-universal-car-t-platform-with-unicar-t/)
- [Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion](https://scholariq.org/papers/exogenous-tnfr2-activation-protects-from-acute-gvhd-via-host-t-reg-cell/)
- [International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation](https://scholariq.org/papers/international-myeloma-working-group-guidelines-for-the-management-of-multiple/)

## Researcher topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Antifungal resistance and susceptibility](https://scholariq.org/topics/antifungal-resistance-and-susceptibility/)

## Researcher university

- [Universitätsklinikum Würzburg](https://scholariq.org/institutions/universitatsklinikum-wurzburg/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.